Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289899/
https://www.ncbi.nlm.nih.gov/pubmed/35860834
http://dx.doi.org/10.1177/17588359221112982
_version_ 1784748768844840960
collection PubMed
description
format Online
Article
Text
id pubmed-9289899
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-92898992022-07-19 Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma” Ther Adv Med Oncol Erratum SAGE Publications 2022-07-15 /pmc/articles/PMC9289899/ /pubmed/35860834 http://dx.doi.org/10.1177/17588359221112982 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Erratum
Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title_full Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title_fullStr Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title_full_unstemmed Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title_short Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
title_sort erratum to “durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma”
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289899/
https://www.ncbi.nlm.nih.gov/pubmed/35860834
http://dx.doi.org/10.1177/17588359221112982

Ejemplares similares